Evaluation of Biomarkers for Predicting Macronutrient Intake

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-06

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to establish the relationship between macronutrient food intake and the resulting blood and intersticial fluid (ISF )levels of small molecule markers, as well as, validate wearable optical readers and data fusion algorithms to accurately predict individual-specific macronutrient availability in real time.

The study involves 1 screening visit of approximately 2 hours and up to 4 study days of approximately 14 hours. Subjects will be asked to arrive in the fasted state on all study days. Fasting prior to screening is not required. On the screening visit, body weight, height, and body composition by Dual-energy X-ray absorptiometry (DXA) will be measured. In addition, habitual dietary intake, physical activity level (PASE), and quality of life (SGRQ-C) will be assessed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Role of Protein in Regulating Ad Libitum Energy Intake in Humans

NCT02613065

Energy Balance

COMPLETED NA

Development of a Marker of Adherence for Tracking Consumption of Nutrient Supplements

NCT04040543

Adherence, Treatment

COMPLETED NA

Nutrient Bioavailability From Microalgae

NCT04567823

Nutrient Deficiency

COMPLETED NA

Optimizing Meal and Snack Timing to Promote Health

NCT02506218

Dietary Modification

COMPLETED NA

An Evaluation of Zinc Status Biomarkers

NCT02861352

Inflammation Oxidative Stress

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

On each study day, body weight and height will be measured. An in-dwelling catheter will be inserted in a peripheral vein of the lower arm or hand to enable blood sampling. The arm will be put in a hot box to allow collecting arterialized venous blood samples. After taking a baseline blood sample, the predefined meal will be consumed within 10 min. Small arterialized venous blood samples (5 ml) will subsequently be drawn multiple times. Samples will be collected in predefined tubes, plasma/serum separated, aliquoted, and stored at -80 deg. Celsius for later assays and/or send to a local accredited laboratory for the concentrations of amino acids and other parameters (including amino acids, fatty acids, glucose, insulin).

In the opposite limb, a commercially available microdialysis catheter will be placed in the forearm following standard operating procedures developed by the European Academy of Allergy \& Clinical Immunology Task Force on Skin Microdialysis. Dialysate will be collected in 30-minute aliquots in microvials for the duration of the study day. Microvials will be weighed before and after sample collection. A syringe filled with perfusate containing mixture of stable tracer-labelled amino acids and glucose will be infused through the syringe pump at a controlled rate.

On each of the study days, subjects will consume two meals with defined composition of macronutrients eight hours apart.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glucose Metabolism Amino Acid Metabolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Laboratory staff and data scientists will not know the meals received when analyzing samples and initial statistical modeling

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy male older adults

Eight predefined, commercially available meal is administered in a randomized fashion. Two meals are consumed 6 hours apart on each study day. Meals are selected to represent a range of fat, protein, and carbohydrate content.

Group Type EXPERIMENTAL

Meal set A

Intervention Type OTHER

morning meal: low carbohydrate, low protein, low fat afternoon meal: high carbohydrate, high protein, high fat

Meal set B

Intervention Type OTHER

morning meal: low carbohydrate, high protien, low fat meal afternoon meal: high carbohydrate, low protein, high fat meal

Meal set C

Intervention Type OTHER

morning meal: low carbohydrate, low protien, low fat meal afternoon meal: high carbohydrate, high protein, low fat meal

Meal set D

Intervention Type OTHER

morning meal: high carbohydrate, low protien, low fat meal afternoon meal: low carbohydrate, high protein, high fat meal

Healthy female older adults

Eight predefined, commercially available meal is administered in a randomized fashion. Two meals are consumed 6 hours apart on each study day. Meals are selected to represent a range of fat, protein, and carbohydrate content.

Group Type EXPERIMENTAL

Meal set A

Intervention Type OTHER

morning meal: low carbohydrate, low protein, low fat afternoon meal: high carbohydrate, high protein, high fat

Meal set B

Intervention Type OTHER

morning meal: low carbohydrate, high protien, low fat meal afternoon meal: high carbohydrate, low protein, high fat meal

Meal set C

Intervention Type OTHER

morning meal: low carbohydrate, low protien, low fat meal afternoon meal: high carbohydrate, high protein, low fat meal

Meal set D

Intervention Type OTHER

morning meal: high carbohydrate, low protien, low fat meal afternoon meal: low carbohydrate, high protein, high fat meal

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Meal set A

morning meal: low carbohydrate, low protein, low fat afternoon meal: high carbohydrate, high protein, high fat

Intervention Type OTHER

Meal set B

morning meal: low carbohydrate, high protien, low fat meal afternoon meal: high carbohydrate, low protein, high fat meal

Intervention Type OTHER

Meal set C

morning meal: low carbohydrate, low protien, low fat meal afternoon meal: high carbohydrate, high protein, low fat meal

Intervention Type OTHER

Meal set D

morning meal: high carbohydrate, low protien, low fat meal afternoon meal: low carbohydrate, high protein, high fat meal

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ability to walk, sit down and stand up independently
* Age 50-75 years old
* Ability to lie in supine or slightly elevated position for approximately 13 hours
* BMI between 25 and 35
* Willingness and ability to comply with the protocol

Exclusion Criteria

* Established diagnosis of malignancy
* Established diagnosis of Insulin or non-Insulin Dependent Diabetes Mellitus
* History of untreated metabolic diseases including hepatic or renal disorder
* Currently on anticoagulants (i.e., warfarin, factor X inhibitors or direct thrombin inhibitors)
* History of deep vein thrombosis, pulmonary embolisms, or known clotting disorders
* Presence of acute illness or metabolically unstable chronic illness
* Recent myocardial infarction (less than 1 year)
* Known allergy or intolerance to any of the meal components
* Any other condition according to the PI or nurse that was found during the screening visit, that would interfere with the study or safety of the patient
* Failure to give informed consent or Investigator\'s uncertainty about the willingness or ability of the participant to comply with the protocol requirements

Minimum Eligible Age

50 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes